Liposomal nanoparticles displaying glycan ligands of CD22 for targeting and killing B-cell lymphoma. (A) Schematic illustration of a chemotherapeutic-loaded liposomal formulation comprising ^BPCNeuAc lipids for active targeting to CD22. (B) Synthesis of ^BPCNeuAc-pegylated lipids.